Remdesivir for COVID-19: Challenges of Underpowered Studies

Lancet. 2020 May 16;395(10236):1525-1527. doi: 10.1016/S0140-6736(20)31023-0. Epub 2020 Apr 29.

Publication types

  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Alanine / analogs & derivatives
  • Antiviral Agents* / therapeutic use
  • Betacoronavirus*
  • Coronavirus Infections*
  • Double-Blind Method
  • Pandemics
  • Pneumonia, Viral
  • Randomized Controlled Trials as Topic

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2